These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26109532)

  • 1. Brief Report: Nonsteroidal Antiinflammatory Drug-Sparing Effect of Tumor Necrosis Factor Inhibitors in Early Axial Spondyloarthritis: Results From the DESIR Cohort.
    Moltó A; Granger B; Wendling D; Breban M; Dougados M; Gossec L
    Arthritis Rheumatol; 2015 Sep; 67(9):2363-8. PubMed ID: 26109532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of tumor necrosis factor α blockers in early axial spondyloarthritis: data from the DESIR cohort.
    Moltó A; Paternotte S; Claudepierre P; Breban M; Dougados M
    Arthritis Rheumatol; 2014 Jul; 66(7):1734-44. PubMed ID: 24623678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early tumor necrosis factor α antagonist therapy in everyday practice for inflammatory back pain suggesting axial spondyloarthritis: results from a prospective multicenter french cohort.
    Canouï-Poitrine F; Poulain C; Molto A; Le Thuaut A; Lafon C; Farrenq V; Ferkal S; Le Corvoisier P; Ghaleh B; Bastuji-Garin S; Fautrel B; Dougados M; Claudepierre P
    Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1395-402. PubMed ID: 24664935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study.
    Dougados M; Wood E; Combe B; Schaeverbeke T; Miceli-Richard C; Berenbaum F; Koppiker N; Dubanchet A; Logeart I
    Arthritis Res Ther; 2014 Nov; 16(6):481. PubMed ID: 25428762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief Report: Six-Week Treatment of Axial Spondyloarthritis Patients With an Optimal Dose of Nonsteroidal Antiinflammatory Drugs: Early Response to Treatment in Signal Intensity on Magnetic Resonance Imaging of the Sacroiliac Joints.
    Varkas G; Jans L; Cypers H; Van Praet L; Carron P; Elewaut D; Van den Bosch F
    Arthritis Rheumatol; 2016 Mar; 68(3):672-8. PubMed ID: 26473982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated With Treatment Pathways in Early Axial Spondyloarthritis: A Multistate Analysis of the 10-Year Follow-Up of the DESIR Cohort.
    Portier E; Chevret S; Walter-Petrich A; Ruyssen-Witrand A; Dougados M; Moltó A
    J Rheumatol; 2024 Apr; 51(4):368-377. PubMed ID: 38359943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief Report: Clinical Course Over Two Years in Patients With Early Nonradiographic Axial Spondyloarthritis and Patients With Ankylosing Spondylitis Not Treated With Tumor Necrosis Factor Blockers: Results From the German Spondyloarthritis Inception Cohort.
    Poddubnyy D; Haibel H; Braun J; Rudwaleit M; Sieper J
    Arthritis Rheumatol; 2015 Sep; 67(9):2369-75. PubMed ID: 26017497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
    Kapetanovic MC; Roseman C; Jönsson G; Truedsson L; Saxne T; Geborek P
    Arthritis Rheum; 2011 Dec; 63(12):3723-32. PubMed ID: 21834061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of nonsteroidal anti-inflammatory drugs in early axial spondyloarthritis in daily practice: Data from the DESIR cohort.
    Molto A; Granger B; Wendling D; Dougados M; Gossec L
    Joint Bone Spine; 2017 Jan; 84(1):79-82. PubMed ID: 27238187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with radiographic lesions in early axial spondyloarthritis. Results from the DESIR cohort.
    Blachier M; Canouï-Poitrine F; Dougados M; Lethuaut A; Fautrel B; Ferkal S; Le Corvoisier P; Farrenq V; Poulain C; Ghaleh B; Bastuji-Garin S; Claudepierre P
    Rheumatology (Oxford); 2013 Sep; 52(9):1686-93. PubMed ID: 23764945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with drug-free remission at 5-year in early onset axial spondyloarthritis patients: Data from the DESIR cohort.
    Ruyssen-Witrand A; Rousseau V; Sommet A; Goupille P; Degboe Y; Constantin A
    Joint Bone Spine; 2022 Jul; 89(4):105358. PubMed ID: 35167972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.
    Poddubnyy D; Rudwaleit M; Haibel H; Listing J; Märker-Hermann E; Zeidler H; Braun J; Sieper J
    Ann Rheum Dis; 2012 Oct; 71(10):1616-22. PubMed ID: 22459541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Spondylarthropathies: conventional treatments and anti-TNF].
    Dumusc A; So A
    Rev Med Suisse; 2016 Mar; 12(509):507-8, 510-1. PubMed ID: 27089640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal antiinflammatory drug intake according to the Assessment of SpondyloArthritis International Society Score in clinical trials evaluating tumor necrosis factor blockers: example of etanercept in advanced ankylosing spondylitis.
    Dougados M; Braun J; Szanto S; Combe B; Geher P; Leblanc V; Logeart I
    Arthritis Care Res (Hoboken); 2012 Feb; 64(2):290-4. PubMed ID: 22006544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ankylosing spondylitis disease activity score is related to NSAID use, especially in patients treated with TNF-α inhibitors.
    Carbo MJG; Spoorenberg A; Maas F; Brouwer E; Bos R; Bootsma H; van der Veer E; Wink F; Arends S
    PLoS One; 2018; 13(4):e0196281. PubMed ID: 29689112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminant Capacity of Clinical Efficacy and Nonsteroidal Antiinflammatory Drug-sparing Endpoints, Alone or in Combination, in Axial Spondyloarthritis.
    Dougados M; Wood E; Gossec L; Dubanchet A; Logeart I; van der Heijde D
    J Rheumatol; 2015 Dec; 42(12):2361-8. PubMed ID: 26568588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with tumor necrosis factor inhibitors in axial spondyloarthritis: comparison between private rheumatology practices and academic centers in a large observational cohort.
    Ciurea A; Weber U; Stekhoven D; Scherer A; Tamborrini G; Bernhard J; Toniolo M; Villiger PM; Zufferey P; Kissling RO; Michel BA; Exer P;
    J Rheumatol; 2015 Jan; 42(1):101-5. PubMed ID: 25362654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive TNF-α antagonists in France? The CORPUS cohort study.
    Saraux A; Benichou J; Guillevin L; Idbrik L; Job-Deslandre C; Sibilia J; Soudant M; Wendling D; Guillemin F
    Clin Exp Rheumatol; 2015; 33(5):602-10. PubMed ID: 26315585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors.
    Subramaniam K; Tymms K; Shadbolt B; Pavli P
    Intern Med J; 2015 Nov; 45(11):1154-60. PubMed ID: 26337851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease activity trajectories in early axial spondyloarthritis: results from the DESIR cohort.
    Molto A; Tezenas du Montcel S; Wendling D; Dougados M; Vanier A; Gossec L
    Ann Rheum Dis; 2017 Jun; 76(6):1036-1041. PubMed ID: 27888172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.